title: Dual-modality, dual-functional nanoprobes for cellular and molecular imaging.
abstract: An emerging need for evaluation of promising cellular therapies is a non-invasive method to image the movement and health of cells following transplantation. However, the use of a single modality to serve this purpose may not be advantageous as it may convey inaccurate or insufficient information. Multi-modal imaging strategies are becoming more popular for in vivo cellular and molecular imaging because of their improved sensitivity, higher resolution and structural/functional visualization. This study aims at formulating Nile Red doped hexamethyldisiloxane (HMDSO) nanoemulsions as dual modality (Magnetic Resonance Imaging/Fluorescence), dual-functional (oximetry/detection) nanoprobes for cellular and molecular imaging. HMDSO nanoprobes were prepared using a HS15-lecithin combination as surfactant and showed an average radius of 71±39 nm by dynamic light scattering and in vitro particle stability in human plasma over 24 hrs. They were found to readily localize in the cytosol of MCF7-GFP cells within 18 minutes of incubation. As proof of principle, these nanoprobes were successfully used for fluorescence imaging and for measuring pO(2) changes in cells by magnetic resonance imaging, in vitro, thus showing potential for in vivo applications.
authors: Department of Radiology, UT Southwestern Medical Center at Dallas, Dallas, TX, USA.
authors: Jyothi U
authors: JU
authors: Menon
authors: Praveen K
authors: PK
authors: Gulaka
authors: Madalyn A
authors: MA
authors: McKay
authors: Sairam
authors: S
authors: Geethanath
authors: Li
authors: L
authors: Liu
authors: Vikram D
authors: VD
authors: Kodibagkar
mesh_terms: D000818:Animals; D002470:Cell Survival; D004705:Endocytosis; D005347:Fibroblasts; D006801:Humans; D061986:MCF-7 Cells; D008279:Magnetic Resonance Imaging; D051379:Mice; D008856:Microscopy, Fluorescence; D057054:Molecular Imaging / Q000379:methods*; D041681:NIH 3T3 Cells; D053758:Nanoparticles / Q000737:chemistry* / Q000648:ultrastructure; D010078:Oxazines / Q000737:chemistry; D010316:Particle Size; D012833:Siloxanes / Q000737:chemistry
chemical_list: D010078:Oxazines; D012833:Siloxanes; C015917:hexamethyldisiloxane; C044808:nile red
keywords: MR oximetry; Nile Red; dual-modality.; fluorescence; hexamethyldisiloxane; nanoemulsions
references: Mol Imaging Biol. 2011 Dec;13(6):1163-72
references: 21080233
references: Methods Enzymol. 2004;386:378-418
references: 15120262
references: Biomaterials. 2010 Apr;31(12):3287-95
references: 20132982
references: FASEB J. 2007 Jun;21(8):1647-54
references: 17284484
references: J Control Release. 2012 Oct 28;163(2):249-55
references: 22902594
references: Tissue Eng Part A. 2008 Aug;14(8):1331-40
references: 18601588
references: Technol Cancer Res Treat. 2006 Aug;5(4):301-9
references: 16866560
references: AJR Am J Roentgenol. 2009 Aug;193(2):314-25
references: 19620426
references: Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2012 May-Jun;4(3):329-43
references: 22354793
references: Analyst. 2011 Oct 7;136(19):4013-9
references: 21804989
references: Arch Pharm Res. 2012 Jun;35(6):1037-43
references: 22870813
references: J Biomed Nanotechnol. 2009 Feb;5(1):62-8
references: 20055107
references: Bioconjug Chem. 2007 Sep-Oct;18(5):1474-82
references: 17711320
references: NMR Biomed. 2004 Nov;17(7):484-99
references: 15526347
references: Oncologist. 2004;9 Suppl 5:31-40
references: 15591420
references: Matrix Biol. 2003 Mar;22(1):81-91
references: 12714045
references: Int J Pharm. 2009 Mar 31;370(1-2):181-6
references: 19073240
references: Q J Nucl Med Mol Imaging. 2010 Jun;54(3):259-80
references: 20639813
references: Genes Dev. 2007 May 1;21(9):1037-49
references: 17437992
references: Org Biomol Chem. 2010 Jan 7;8(1):201-11
references: 20024151
references: Magn Reson Med. 2006 Apr;55(4):743-8
references: 16506157
references: Clin Cancer Res. 2003 Jun;9(6):1957-71
references: 12796357
references: Cancer Res. 1991 Feb 1;51(3):897-902
references: 1988130
references: NMR Biomed. 2011 Dec;24(10):1226-34
references: 21412864
references: Nanoscale. 2011 Jan;3(1):142-53
references: 20938522
references: Eur Cell Mater. 2011 Apr 11;21:341-54
references: 21484704
references: Neuroimage. 2004 Jan;21(1):311-7
references: 14741669
references: Biophys J. 2003 Feb;84(2 Pt 1):1291-8
references: 12547809
references: Nano Lett. 2006 Jul;6(7):1459-63
references: 16834429
references: NMR Biomed. 2008 Oct;21(8):899-907
references: 18574806
references: Exp Biol Med (Maywood). 2010 Aug;235(8):957-65
references: 20660096
references: Anal Biochem. 2010 Jan 15;396(2):250-6
references: 19766582
references: Tissue Eng. 2007 Jun;13(6):1325-31
references: 17518749
references: Int J Pharm. 2002 Sep 5;244(1-2):21-31
references: 12204562
references: Trends Mol Med. 2010 Dec;16(12):574-83
references: 20870460
references: Neoplasia. 2012 Oct;14(10):964-73
references: 23097630
references: Acta Pharm. 2006 Dec;56(4):417-29
references: 19839134
references: Curr Pharm Biotechnol. 2004 Dec;5(6):567-84
references: 15579045
references: Eur Heart J. 2010 Jun;31(11):1410-20
references: 20023288
references: Magn Reson Med. 2011 Apr;65(4):1144-53
references: 21305593
references: PLoS One. 2011;6(12):e29040
references: 22216163
references: PLoS One. 2012;7(11):e50575
references: 23226317